Nivolumab in Combination With Plinabulin in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC)
Non-small Cell Lung Cancer Metastatic, Metastatic, NSCLC, nivolumab, plinabulin, BPI-2358, opdivo, Non-Small Cell Lung Cancer, cancer, Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Nivolumab + Plinabulin
Lead Scientist at UC Cancer
- Lyudmilla Bazhenova, MD (ucsd)
Dr. Bazhenova’s clinical practice and research concentrate on lung cancer, particularly as this relates to females and non-smokers. She actively participates in cooperative group trials, and takes an active role in designing and implementing clinical investigations, including phase II studies and correlative science projects with several UCSD investigators.
- accepting new patients
- Start Date
- Completion Date
- Lyudmila Bazhenova, M.D.
- Phase 1 research study
- Study Type
- Expecting 38 study participants
- Last Updated